Cytokinetics, Incorporated (CYTK)
NASDAQ · Healthcare
Cytokinetics, Incorporated Long Term Debt 2009–2025
Cytokinetics, Incorporated annual/quarterly long term debt history from 2015 to 2025. Long term debt refers to financial obligations that are due more than one year in the future.
- Cytokinetics, Incorporated long term debt for the quarter ending December 31, 2025 were 246.4M, a 60.23% decrease year-over-year.
- Cytokinetics, Incorporated long term debt for 2025 were 246.4M, a 60.23% decrease from 2024.
- Cytokinetics, Incorporated long term debt for 2024 were 619.5M, a 3.09% decrease from 2023.
- Cytokinetics, Incorporated long term debt for 2023 were 639.3M, a 1.58% decrease from 2022.
- Cytokinetics, Incorporated long term debt for 2022 were 649.6M.
Long Term Debt
QUARTERLY · $B
YOY QUARTERLY GROWTH · %
| Cytokinetics, Incorporated Annual Long Term Debt (Millions of US $) | |
|---|---|
| 2025 | $246 |
| 2024 | $620 |
| 2023 | $639 |
| 2022 | $650 |
| 2021 | $47 |
| 2020 | $46 |
| 2019 | $45 |
| 2018 | $42 |
| 2017 | $32 |
| 2016 | $30 |
| 2015 | $15 |
| Cytokinetics, Incorporated Quarterly Long Term Debt (Millions of US $) | |
|---|---|
| 2025-12-31 | $246 |
| 2024-12-31 | $620 |
| 2023-12-31 | $639 |
| 2022-12-31 | $650 |
| 2021-12-31 | $47 |
| 2020-12-31 | $46 |
| 2019-12-31 | $45 |
| 2018-12-31 | $42 |
| 2017-12-31 | $32 |
| 2016-12-31 | $30 |
| 2015-12-31 | $15 |
Cytokinetics, Incorporated Long Term Debt — FAQ
Cytokinetics, Incorporated (CYTK) long term debt over the last 17 years — annual and quarterly figures with year-over-year growth and charts.
Where can I see CYTK's long term debt history?
The chart and table above show Cytokinetics, Incorporated's long term debt by year and by quarter, including the growth rate.